A COMPARATIVE STUDY OF SYSTEMS PHARMACOLOGY AND GENE EXPRESSION MODELS FOR PREDICTING DRUG TARGETS
Main Article Content
Keywords
Drug target prediction; systems pharmacology; gene expression; computational pharmacology; network analysis; drug discovery
Abstract
Background: Accurate prediction of drug targets remains a fundamental challenge in pharmaceutical research and drug discovery. Systems pharmacology and gene expression-based approaches represent two predominant computational strategies for target identification, yet comprehensive comparisons of their predictive performance are lacking. This study aimed to systematically compare the accuracy, sensitivity, and specificity of systems pharmacology models versus gene expression models in predicting validated drug targets.
Methods: This comparative computational study analyzed 1,247 drug-target interactions from established pharmacological databases. Systems pharmacology models incorporating network topology, pathway enrichment, and protein-protein interaction data were compared against gene expression models utilizing differential expression analysis and co-expression network approaches. Performance metrics including accuracy, sensitivity, specificity, positive predictive value, and area under the receiver operating characteristic curve (AUC-ROC) were calculated. Validation was performed using an independent dataset of 312 experimentally confirmed drug-target pairs.
Results: Systems pharmacology models demonstrated superior overall accuracy (78.4 ± 5.2%) compared to gene expression models (71.6 ± 6.8%; p<0.001). The AUC-ROC values were 0.847 ± 0.042 for systems pharmacology and 0.793 ± 0.051 for gene expression approaches. However, gene expression models showed higher sensitivity for detecting novel targets (82.3% vs. 74.6%; p=0.008). Integration of both approaches yielded optimal performance, achieving 86.2 ± 4.1% accuracy and AUC-ROC of 0.912 ± 0.031. The integrated model successfully predicted 89.4% of validated targets in the independent dataset.
Conclusion: While systems pharmacology models demonstrate superior overall accuracy for drug target prediction, gene expression approaches offer complementary advantages in novel target discovery. Integrated computational frameworks combining both methodologies provide optimal predictive performance and should be prioritized in drug discovery pipelines.
References
2. Sams-Dodd F. Target-based drug discovery: is something wrong? Drug Discov Today. 2005;10(2):139-147. doi:10.1016/S1359-6446(04)03316-1. PMID: 15718163
3. Butcher EC, Berg EL, Kunkel EJ. Systems biology in drug discovery. Nat Biotechnol. 2004;22(10):1253-1259. doi:10.1038/nbt1017. PMID: 15470465
4. Cooke EJ, Savage RS, Wild DL. Computational approaches to the integration of gene expression, ChIP-chip and sequence data in the inference of gene regulatory networks. Semin Cell Dev Biol. 2009 Sep;20(7):863-8. doi: 10.1016/j.semcdb.2009.08.004. Epub 2009 Aug 12. PMID: 19682595.
5. Ideker T, Sharan R. Protein networks in disease. Genome Res. 2008 Apr;18(4):644-52. doi: 10.1101/gr.071852.107. PMID: 18381899; PMCID: PMC3863981.
6. Yildirim MA, Goh KI, Cusick ME, Barabási AL, Vidal M. Drug-target network. Nat Biotechnol. 2007;25(10):1119-1126. doi:10.1038/nbt1338. PMID: 17921997
7. Hopkins AL. Drug discovery: predicting promiscuity. Nature. 2009;462(7270):167-168. doi:10.1038/462167a. PMID: 19907487
8. Lamb J. The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer. 2007;7(1):54-60. doi:10.1038/nrc2044. PMID: 17186018
9. Lamb J, Crawford ED, Peck D, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313(5795):1929-1935. doi:10.1126/science.1132939. PMID: 17008526
10. Iorio F, Bosotti R, Scacheri E, et al. Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc Natl Acad Sci USA. 2010;107(33):14621-14626. doi:10.1073/pnas.1000138107. PMID: 20679242
11. Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005;4:Article17. doi:10.2202/1544-6115.1128. PMID: 16646834
12. Keiser MJ, Setola V, Irwin JJ, et al. Predicting new molecular targets for known drugs. Nature. 2009;462(7270):175-181. doi:10.1038/nature08506. PMID: 19881490
13. Arrell DK, Terzic A. Network systems biology for drug discovery. Clin Pharmacol Ther. 2010;88(1):120-125. doi:10.1038/clpt.2010.91. PMID: 20520602
14. Csermely P, Agoston V, Pongor S. The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol Sci. 2005;26(4):178-182. doi:10.1016/j.tips.2005.02.007. PMID: 15808341
15. Mencher SK, Wang LG. Promiscuous drugs compared to selective drugs (promiscuity can be a virtue). BMC Clin Pharmacol. 2005;5:3. doi:10.1186/1472-6904-5-3. PMID: 15854222
16. Ashburn TT, Thor KB. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004 Aug;3(8):673-83. doi: 10.1038/nrd1468. PMID: 15286734.
17. Campillos M, Kuhn M, Gavin AC, Jensen LJ, Bork P. Drug target identification using side-effect similarity. Science. 2008;321(5886):263-266. doi:10.1126/science.1158140. PMID: 18621671
18. Pujol A, Mosca R, Farrés J, Aloy P. Unveiling the role of network and systems biology in drug discovery. Trends Pharmacol Sci. 2010;31(3):115-123. doi:10.1016/j.tips.2009.11.006. PMID: 20117850
19. Bleakley K, Yamanishi Y. Supervised prediction of drug-target interactions using bipartite local models. Bioinformatics. 2009 Sep 15;25(18):2397-403. doi: 10.1093/bioinformatics/btp433. Epub 2009 Jul 15. PMID: 19605421; PMCID: PMC2735674.
20. Berger SI, Iyengar R. Network analyses in systems pharmacology. Bioinformatics. 2009;25(19):2466-2472. doi:10.1093/bioinformatics/btp465. PMID: 19648136
21. Yamanishi Y, Araki M, Gutteridge A, Honda W, Kanehisa M. Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics. 2008;24(13):i232-i240. doi:10.1093/bioinformatics/btn162. PMID: 18586719
22. van der Greef J, McBurney RN. Innovation: Rescuing drug discovery: in vivo systems pathology and systems pharmacology. Nat Rev Drug Discov. 2005;4(12):961-967. doi:10.1038/nrd1904. PMID: 16341063
23. Fliri AF, Loging WT, Thadeio PF, Bhati RA. Biospectra analysis: model proteome characterizations for linking molecular structure and biological response. J Med Chem. 2005;48(22):6918-6925. doi:10.1021/jm050494g. PMID: 16250651.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Amar Jeeth Raja R
Department of Pharmacology Assistant Professor Sri Lakshmi Narayana Institute of Medical Sciences, Osudu, Agaram Village, Villianur Commune, Kudapakkam Post, Puducherry- 605502
